The complement system in the acute phase of myocardial infarction.
Although some studies suggest that complement activation is involved in the development of acute myocardial infarction, there has been little convincing evidence of a change in the complement system in patients suffering from myocardial infarction. In this study circulating levels of C3a, C3, C4 and the total hemolytic complement titer (CH50) were serially measured in 12 patients with acute myocardial infarction up to 10 days after an attack. The plasma C3a level was greatly elevated throughout the post-attack observation period. The C3, C4 and CH50 levels were significantly increased above those controls on days 8, 9 and 10 after infarction. These findings indicate that there is complement activation in patients with acute myocardial infarction, and suggest a pathogenetic role for complement activation in the development of myocardial damage after infarction.
Yasuda
M
M
First Department of Internal Medicine, Osaka City University Medical School, Japan.
Kawarabayashi
T
T
Akioka
K
K
Teragaki
M
M
Oku
H
H
Kanayama
Y
Y
Takeuchi
K
K
Takeda
T
T
Kawase
Y
Y
Ikuno
Y
Y
D000210:Acute-Phase Reaction / Q000209:etiology / Q000276:immunology*; D000368:Aged; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism; D015926:Complement C3a / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D015941:Complement Hemolytic Activity Assay; D003165:Complement System Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000276:immunology*
D003176:Complement C3; D003181:Complement C4; D015926:Complement C3a; D003165:Complement System Proteins